Search - tctmd.com

Displaying 941 - 960 of 1273

Sort: Relevancy | Date

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Daily News

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

L.A. McKeown

November 08, 2017

Presentation TCT 2017

Use of NCDR Registries to Evaluate Race and Gender Issues Related to Medications and Devices

Presenter: Alice K. Jacobs, Spencer B. King III, John C. Messenger

October 31, 2017

News Conference News TCT 2017

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

Yael L. Maxwell

October 31, 2017

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

Presentation TCT 2017

EFS Experiences and Recommendations: A Major Device Company Perspective

Presenter: Andrew Farb, Aaron V. Kaplan, Donald E. Bobo Jr

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Sara Takahashi

October 30, 2017

Presentation TCT 2017

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Presenter: Wayne B. Batchelor, George A. Mensah, Christopher J Popma

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Nicole Milligan

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Industry View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Lisa Becker

October 30, 2017

Presentation TCT 2017

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

Presenter: Mitchell W. Krucoff, John C Laschinger, Daniel A Canos

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Industry View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Declan Dineen

October 30, 2017

Presentation TCT 2017

Current CV Device Use and Unmet Needs in Children: US Academic View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Frank F. Ing

October 30, 2017

Presentation TCT 2017

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

Presenter: Mitchell W. Krucoff, John C Laschinger, E. Murat Tuzcu

October 30, 2017

Presentation TCT 2017

Current CV Device Use and Unmet Needs in Children: Japanese Academic View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Hideshi Tomita

October 30, 2017

Presentation TCT 2017

Introduction and Achievement of HBD-for-Children

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Yasuko Nakamura

October 30, 2017

Presentation TCT 2017

EFS in Japan & USA: Industry View

Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Robert Thatcher

October 30, 2017

Presentation TCT 2017

EFS in Japan: PMDA View

Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Sara Takahashi

October 30, 2017

Presentation TCT 2017

Do Japanese Patients & Doctors Want EFS: Academic View

Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Shigeru Saito

October 30, 2017

Presentation TCT 2017

EFS FDA Guidance: History & Overview

Presenter: Mitchell W. Krucoff, Kiyohito Nakai, Andrew Farb

October 30, 2017

Advertisement

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Positionable Shields Slash Radiation Exposure to Cath Lab Staff by Two-Thirds

Use of NCDR Registries to Evaluate Race and Gender Issues Related to Medications and Devices

Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

EFS Experiences and Recommendations: A Major Device Company Perspective

The Landscape of CV Device Innovation for Children: Regulatory View

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

The Landscape of CV Device Innovation for Children: Regulatory View

The Landscape of CV Device Innovation for Children: Industry View

CMS Perspectives on Post-Approval Device Evaluation(Including NEST) and Reimbursement

The Landscape of CV Device Innovation for Children: Industry View

Current CV Device Use and Unmet Needs in Children: US Academic View

Can Post-Approval Registries Inform Device Label Expansion? The TVT Case Example

Current CV Device Use and Unmet Needs in Children: Japanese Academic View

Introduction and Achievement of HBD-for-Children

EFS in Japan & USA: Industry View

EFS in Japan: PMDA View

Do Japanese Patients & Doctors Want EFS: Academic View

EFS FDA Guidance: History & Overview

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content